Compare NMR & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NMR | WAT |
|---|---|---|
| Founded | 1925 | 1958 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.2B | 33.5B |
| IPO Year | 2002 | 1996 |
| Metric | NMR | WAT |
|---|---|---|
| Price | $9.72 | $411.77 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 17 |
| Target Price | N/A | ★ $379.19 |
| AVG Volume (30 Days) | 791.9K | ★ 882.6K |
| Earning Date | 04-24-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.19% | N/A |
| EPS Growth | N/A | ★ 0.47 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.00 | $104.66 |
| Revenue Next Year | $4.76 | $10.40 |
| P/E Ratio | $12.03 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.71 | $282.77 |
| 52 Week High | $10.06 | $421.74 |
| Indicator | NMR | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 52.07 | 60.16 |
| Support Level | $9.29 | $372.18 |
| Resistance Level | $10.00 | N/A |
| Average True Range (ATR) | 0.12 | 12.45 |
| MACD | -0.06 | -0.23 |
| Stochastic Oscillator | 43.70 | 77.56 |
Nomura Holdings Inc is a financial services group in Japan and operates offices in countries and regions world-wide, including Japan, the U.S., the U.K., Singapore, and the Hong Kong Special Administrative Region ("Hong Kong") through its subsidiaries. The company's clients include individuals, corporations, financial institutions, governments, and governmental agencies. The company's business consists of Wealth Management*, Investment Management, and Wholesale. The company generates the majority of its revenue from the wholesale segment. The Wholesale Division consists of two businesses, Global Markets, which is mainly engaged in the trading, sales, and structuring of financial products, and Investment Banking, which is engaged in advisory, financing, and solutions businesses.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.